Financial

Certilytics and IKS Health Bolster Strategic Partnership with New Agentic AI and Expert-in-the-Loop Oversight to Improve Healthcare Workflows and Impact Across the Patient Journey

SAN FRANCISCO, April 21, 2026 /PRNewswire/ -- Certilytics Inc., a leading innovator in AI-driven healthcare intelligence, today announced the expansion of...

Certilytics and IKS Health Bolster Strategic Partnership with New Agentic AI and Expert-in-the-Loop Oversight to Improve Healthcare Workflows and Impact Across the Patient Journey

SAN FRANCISCO, April 21, 2026 /PRNewswire/ -- Certilytics Inc., a leading innovator in AI-driven healthcare intelligence, today announced the expansion of...

Certilytics and IKS Health Bolster Strategic Partnership with New Agentic AI and Expert-in-the-Loop Oversight to Improve Healthcare Workflows and Impact Across the Patient Journey

SAN FRANCISCO, April 21, 2026 /PRNewswire/ -- Certilytics Inc., a leading innovator in AI-driven healthcare intelligence, today announced the expansion of...

BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease

Collaboration aims to identify biological signatures and patient subpopulations most likely to benefit from BioAegis’ recombinant human plasma gelsolin (rhu-pGSN),...

Flatiron Health Publishes First Peer-Reviewed Validation Framework for AI-Extracted Real-World Oncology Data in Journal of Clinical Oncology

Three-pillar framework sets methodological benchmark for data quality and transparency in oncology dataNEW YORK--(BUSINESS WIRE)--Flatiron Health today announced the publication...

BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting

DRAGEN v4.5 supports Illumina’s new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

Illumina launches DRAGEN v4.5, unlocking deep biological signals in complex regions and challenging sample types for rare disease, oncology research...

error: Content is protected !!